Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe
HIV Medicine · 2025
DOI: 10.1111/hiv.70070 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift HIV Medicine, 2025. Verfasst von European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group. Hauptthemen laut MEDLINE: HIV Infections, Dideoxynucleosides, Anti-HIV Agents, Tenofovir. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences, Medical Research Council.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective To compare BMI‐for‐age z ‐score (zBMI) changes in treatment‐experienced children and young people living with HIV aged 6 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- Gilead Sciences
- Medical Research Council
Zitieren
APA
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group (2025). Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe. HIV Medicine. https://doi.org/10.1111/hiv.70070
Vancouver
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group. Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe. HIV Medicine. 2025. doi:10.1111/hiv.70070
BibTeX
@article{EuropeanPregnancyandPaediatricInfectionsCohortCollaborationEPPICCStudyGroup2025,
author = {European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group, European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group},
title = {Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70070}
}
EUVIMED